MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KROS made $244,061K in revenue. $87,014K in net income. Net profit margin of 35.65%.

Income Overview

Revenue
$244,061K
Net Income
$87,014K
Net Profit Margin
35.65%
EPS
$2.3
Unit: Thousand (K) dollars
Revenue Breakdown
    • License
    • Service Other

Income Statement
2025-12-31
Total revenue
244,061
Research and development
129,643
General and administrative
46,849
Total operating expenses
176,492
Income (loss) from operations
67,569
Research and development incentive income
0
Dividend income
24,867
Other expense, net
-539
Total other income, net
24,328
Income (loss) before income taxes
91,897
Income tax provision
4,883
Net income (loss)
87,014
Basic EPS
2.34
Diluted EPS
2.3
Basic Average Shares
37,221,211
Diluted Average Shares
37,859,106
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
License$205,355K Service Other$38,706K Total revenue$244,061K Dividend income$24,867K Income (loss) fromoperations$67,569K Total other income,net$24,328K Total operatingexpenses$176,492K Other expense, net-$539K Income (loss) beforeincome taxes$91,897K Research and development$129,643K General andadministrative$46,849K Net income (loss)$87,014K Income tax provision$4,883K

Keros Therapeutics, Inc. (KROS)

Keros Therapeutics, Inc. (KROS)